A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma

Citations Over TimeTop 1% of 2015 papers

Abstract

Risk stratification utilizing the proposed decision-making framework will improve the ability of clinicians to recognize individual patients with proven or probable PMC who are most likely to benefit from an active surveillance management option while at the same time identifying patients with proven or probable PMC that would be better served with an upfront biopsy and surgical management approach.

Related Papers

• → Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013(2017)2,150 cited
• → Thyroid Cancer Screening in South Korea Increases Detection of Papillary Cancers with No Impact on Other Subtypes or Thyroid Cancer Mortality(2016)213 cited
• → The Acceleration in Papillary Thyroid Cancer Incidence Rates is Similar Among Racial and Ethnic Groups in the United States(2013)90 cited
• → Lessons from Mouse Models of Thyroid Cancer(2009)52 cited
• → CDK12 promotes papillary thyroid cancer progression through regulating the c-myc/β-catenin pathway(2020)20 cited